Navigation Links
Ekkyo Presents a Positive Assessment one Year After the Launch of EkkyLite(TM), its New Scar Healing System
Date:10/8/2009

MARSEILLE, France, October 8 /PRNewswire/ -- Ekkyo(TM), a photomedicine company that develops first-in-class laser-based systems for skin scar prevention and reduction is presenting today, one year after the commercial launch of EkkyLite(TM), its assessment through some key figures:

    - More than 50 French surgeons have used the EkkyLite(TM) system
    - Almost 200 patients have been treated during surgical operations,
      directly in the operating room
    - 10 French centres are already equipped with the EkkyLite(TM) laser,
      allowing coverage of the main regions in France
    - 8 foreign countries are now working with EkkyLite(TM) through a network
      of distributors

Ekkyo has also set up a national register to log and measure the development of the healing process for each patient treated. This confidential register provides personalised access for each practitioner equipped with an EkkyLite (TM) system, allowing them to register the patients treated and also giving them the possibility of publishing scientific articles related to the results obtained.

"This register is a genuine multicentre database updated in real time," comments Alain Cornil, Ekkyo's CEO.

"The development of EkkyLite(TM), both in France and abroad, confirms the potential of our approach and allows us, in return, to enrich our clinical database," adds Cornil "Thanks to this enlarged palette of users, we will very soon be able to present new clinical results."

In the final quarter of 2009, Ekkyo continues to progress and will present EkkyLite(TM) at a national level and, thanks to its network of distributors at an international level, at the following conventions: 10 October: EkkyLite(TM) will be represented by the Austrian distributor, STRADIS, at a convention organised by Austrian Plastic Surgery Society. Alexandre Capon, reference surgeon, will also speak on the LASH (Laser Assisted Skin Healing) technique during the lunch symposia. 16 October: Portuguese plastic surgery convention in Lisbon. From the 23 to the 27 October: plastic surgery 2009 in Seattle. An international convention bringing together more than 3000 surgeons from all over the world. From the 23 to the 25 November: An undisputed name in the world of plastic surgery, the Societe Francaise de Chirurgie Plastique, Reparatrice et Esthetique (SOFCPRE - French Society of Plastic, Reconstructive and Aesthetic Surgery) is organising its 54th convention this year at the CNIT in Paris. The Ekkyo team will be present on stand number 29 and will have the opportunity to officially announce the results of the clinical study carried out since 2007.

About Ekkyo

Created in 2006, Ekkyo is a photomedicine company that develops and markets first-in-class scar-healing devices to reduce scarring and improve post-surgical comfort.

The first laser-assisted skin healing system and the first product marketed by the company, EkkyLite(TM) assists the surgeon right after the critical moment of wound closure, at the early stage of the skin-healing process. By applying a precisely controlled heat stress early in the inflammatory phase of the skin healing process, EkkyLite(TM) makes possible to stimulate and accurately control the balance between skin repair and regeneration. Results confirm the benefits if this LASH(R) (Laser Assisted Skin Healing) technology: enhanced healing with a significantly reduced scar thus repaired tissue is similar to normal skin in its structure.

By this new approach Ekkyo's ambition is to make laser technology available to all, to surgeons first and tomorrow to all doctors facing skin healing issues, and so to contribute to improve the comfort of the intervention and the quality of life of the 70 million patients who are confronted every year to problems of skin healing.

Based in Aix en Provence, France, Ekkyo has 20 staff members as of September 2009.

More on http://www.ekkyo.com

SOURCE Ekkyo


'/>"/>
SOURCE Ekkyo
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Ekkyo Describes the First Benefits of Controlled Hyperthermia in Humans in "Lasers in Surgery and Medicine"
2. InteKrin Therapeutics Presents Positive Long Term INT131 Preclinical Cardiovascular Safety Data at the 45th Annual European Association for the Study of Diabetes Meeting
3. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
4. Nektar Presents Data Demonstrating Favorable Oral Bioavailability and Drug-Drug Interaction Profile for NKTR-118
5. NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009
6. Curemark CEO Presents at Epigenomics Conference
7. Neurocrine Biosciences Presents Elagolix Data
8. Tolerx Presents Data at 69th Scientific Sessions of the American Diabetes Association
9. Micromet Presents Update on Blinatumomabs Response Rate and Duration in a Phase 1 Study in Non-Hodgkins Lymphoma Patients
10. Proteolix Presents Positive Clinical Data for Carfilzomib in Multiple Myeloma at the 2009 ASCO Annual Meeting
11. Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Feb. 8, 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: ... injectable drug delivery systems, today announced that it will release ... December 31, 2015 after market close on February 9, 2016. ... call to discuss these financial results.    About ... --> About Unilife Corporation ...
(Date:2/8/2016)... NORTHBROOK, Ill. , Feb. 8, 2016  Astellas Pharma ... today announced the promotion of James Robinson as ... the company,s operations in North and South America ... president, Astellas Pharma US, representing the commercial organization in ... assumed in 2013. Masao Yoshida , who ...
(Date:2/8/2016)... Palatin Technologies, Inc. (NYSE MKT: PTN), ... for the treatment of diseases with significant unmet ... the United States Patent and Trademark Office (USPTO) ... Patent Application Serial Number 14/313,258 (the ,258 application).  ... female sexual dysfunction using the formulation and dose ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... ... Remember the old saying “rub some dirt on it”? Perhaps you should try ... Clay” the health benefits of integrating clay into a daily diet are numerous, as ... motivational speaker, Perry A~ has since dedicated her life to learning about the benefits ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... wide variety of organizations. DocuSyst provides a cloud hosted environment for FileHold ... installations include integration with various 3rd party applications using the FileHold web services ...
(Date:2/8/2016)... ... 2016 , ... GrassrootsHealth published data from its D*action public ... in the GrassrootsHealth cohort with substantially higher vitamin D levels than a cohort ... states Carole Baggerly, Director of GrassrootsHealth, “the safety and benefits of vitamin ...
(Date:2/8/2016)... (PRWEB) , ... February 08, 2016 , ... TopConsumerReviews.com recently ... in Mole removal products. , Moles are derived from a cluster of melanin when ... all the wrong places and create a lifetime of embarrassment. Historically, mole removal ...
(Date:2/8/2016)... ... , ... Guruji Mahendra Kumar Trivedi is offering 3 days of accelerated personal ... birthday on February 10th. During this time, people can achieve better health, greater ... people from over 40 different countries as an “ordinary man with an extraordinary gift.” ...
Breaking Medicine News(10 mins):